Clinical features, genomic profiling, and outcomes of adult patients with unifocal Langerhans cell histiocytosis.

Authors:
Lang M; Cai HC; Lin H; Chang L; Dai JW and 5 more

Journal:
Orphanet J Rare Dis

Publication Year: 2023

DOI:
10.1186/s13023-023-02989-8

PMCID:
PMC10691033

PMID:
38037140

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Orphanet J Rare Dis

Abbreviation: Orphanet J Rare Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accelerating drug development for amyotrophic lateral sclerosis: construction and application of a …
Cai R; Yang J; Wu L and 4 more (2024) - Transparency Score: 3/6
A position statement on the post gene-therapy rehabilitation of aromatic I-amino acid decarboxylase…
Lee HM; Mercimek-Andrews S; Horvath G and 7 more (2024) - Transparency Score: 3/6
Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COME…
Boentert M; Berger KI; Díaz-Manera J and 7 more (2024) - Transparency Score: 4/6
Are the European reference networks for rare diseases ready to embrace machine learning? A mixed-me…
Iskrov G; Raycheva R; Kostadinov K and 8 more (2024) - Transparency Score: 3/6
A review and recommendations for oral chaperone therapy in adult patients with Fabry disease.
Nowicki M; Bazan-Socha S; Błażejewska-Hyżorek B and 11 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study was approved by the Ethics Committee of Peking Union Medical College Hospital. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This study was funded by the Beijing Natural Science Haidian frontier Foundation (Grant No. L222081 to CXX), the National Key R&D Program of China, Ministry of Science and Technology of the People’s Republic of China (2022YFC2304605), and the National High Level Hospital Clinical Research Funding (2022-PUMCH-B-046)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025